Evodiamine inhibits EPRS expression to regulate glutamate metabolism and proliferation of oral squamous cell carcinoma cells
The Kaohsiung Journal of Medical Sciences · 2024
DOI: 10.1002/kjm2.12803 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Kaohsiung Journal of Medical Sciences, 2024. Verfasst von Li-Qi Lin und 6 weiteren Autor:innen. Beteiligte Einrichtung: School/Hospital of Stomatology, Lanzhou University, Lanzhou, Gansu, China. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Mouth Neoplasms, Quinazolines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Hospital of Stomatology Lanzhou University Scientific Research Project, the Scientific and Technological Foundation of Gansu Province.
Abstract (Originalsprache)
The effects of evodiamine (EVO) on oral squamous cell carcinoma (OSCC) are not yet understood. Based on our earlier findings, we hypothesized that evodiamine may affect OSCC cell proliferation and glutamate metabolism by modulating the expression of EPRS (glutamyl‐prolyl‐tRNA synthetase 1). From GEPIA, we obtained EPRS expression data in patients with OSCC as well as survival prognosis data. An animal model using Cal27 cells in BALB/c nude mice was established. The expression of EPRS was assessed by immunofluorescence, Western blotting, and quantitative PCR. Glutamate measurements were performed to evaluate the impact of evodiamine on glutamate metabolism of Cal27 and SAS tumor cells. transient transfection techniques were used to knock down and modulate EPRS in these cells. EPRS is expressed at higher levels in OSCC than in normal tissues, and it predicts poor prognosis in patients. In a nude mouse xenograft model, evodiamine inhibited tumor growth and the expression of EPRS. Evodiamine impacted cell proliferation, glutamine metabolism, and EPRS expression on Cal27 and SAS cell lines. In EPRS knockdown cell lines, both cell proliferation and glutamine metabolism are suppressed. EPRS's overexpression partially restores evodiamine's inhibitory effects on cell proliferation and glutamine metabolism. This study provides crucial experimental evidence supporting the potential therapeutic application of evodiamine in treating OSCC. Evodiamine exhibits promising anti‐tumor effects by targeting EPRS to regulate glutamate metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School/Hospital of Stomatology, Lanzhou University, Lanzhou, Gansu, China.
- Clinical Research Center for Oral Diseases, Lanzhou, Gansu Province, China.
Förderung
- Hospital of Stomatology Lanzhou University Scientific Research Project
- the Scientific and Technological Foundation of Gansu Province
Zitieren
APA
Lin, L. Q., Lv, S. Y., Ren, H. Z., Li, R. R., Li, L., Pang, Y. Q., & Wang, J. (2024). Evodiamine inhibits EPRS expression to regulate glutamate metabolism and proliferation of oral squamous cell carcinoma cells. The Kaohsiung Journal of Medical Sciences. https://doi.org/10.1002/kjm2.12803
Vancouver
Lin LQ, Lv SY, Ren HZ, Li RR, Li L, Pang YQ, et al. Evodiamine inhibits EPRS expression to regulate glutamate metabolism and proliferation of oral squamous cell carcinoma cells. The Kaohsiung Journal of Medical Sciences. 2024. doi:10.1002/kjm2.12803
BibTeX
@article{Lin2024,
author = {Lin, Li-Qi and Lv, Si-Yi and Ren, Hao-Zhe and Li, Rong-Rong and Li, Lin and Pang, Yun-Qing and Wang, Jing},
title = {Evodiamine inhibits EPRS expression to regulate glutamate metabolism and proliferation of oral squamous cell carcinoma cells},
journal = {The Kaohsiung Journal of Medical Sciences},
year = {2024},
doi = {10.1002/kjm2.12803}
}
EUVIMED